Prospective Study Utilizing PET-CT and Next-Generation Sequencing to Evaluate for Peri-CAR T-Cell Non-CNS Extramedullary Disease in B-Acute Lymphoblastic Leukemia
Brynn B. Duncan(Center for Cancer Research), Nirali N. Shah(National Institutes of Health), Victoria M. Giordani(National Institutes of Health), Alexander W. Rankin(National Institutes of Health), Toni Foley, R. Taylor Sundby(National Cancer Institute), Alexandra Dreyzin(National Cancer Institute), Sara Silbert(National Institutes of Health), Evrim Türkbey(National Institutes of Health Clinical Center), Esther Mena(National Institutes of Health), Hao‐Wei Wang(Fu Jen Catholic University), Grace Li(Baylor College of Medicine), John C. Molina, Chloe Hoang(National Institutes of Health), Constance M. Yuan(National Cancer Institute)
Cited by 0
Related Papers
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
|Genes & Development|2010|744
CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
|Journal of Clinical Oncology|2020|422
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion
|Nature Reviews Clinical Oncology|2022|324